Revance TherapeuticsRVNC 
$3.07-0.65%24h
-0.65%24h
Global rank3137
Market cap$269.59M
Change 7d1.66%
YTD Performance-65.93%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Revance Therapeutics (RVNC)
As of December 2024, Revance Therapeutics has a market cap of $269.59M. This makes Revance Therapeutics the world's 3137th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Revance Therapeutics from 2014 to 2024
-
Value:-
Market cap history of Revance Therapeutics from 2014 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $481.22M | -37.66% |
| 2023 | $771.88M | -52.38% |
| 2022 | $1.62B | 13.11% |
| 2021 | $1.43B | -42.41% |
| 2020 | $2.49B | 74.61% |
| 2019 | $1.43B | -19.37% |
| 2018 | $1.77B | -43.69% |
| 2017 | $3.14B | 72.71% |
| 2016 | $1.82B | -39.40% |
| 2015 | $3.00B | 101.65% |
| 2014 | $1.49B | - |
RVNC Market Cap Today is $269.59M -0.65% - 18 Dec 2024
View largest stocks by market cap 
